Daniel Eisenkraft Klein

RunWithRugs · 2026-03-31T23:49:41+00:00

Daniel Eisenkraft Klein, a postdoctoral fellow at Harvard Medical School, focuses on pharmaceutical governance and ethics, exploring stakeholder engagement in regulatory settings and drug policy, particularly regarding opioids and psychedelics. He holds degrees from McGill and the University of Toronto.

RunWithRugs

2026-03-31 23:49:41

Abstract generation in progress

(MENAFN- The Conversation)

Postdoctoral Fellow, Harvard University

Profile Articles Activity

Daniel Eisenkraft Klein, PhD, MSc is a postdoctoral research fellow at the Program On Regulation, Therapeutics, And Law at Harvard Medical School and Brigham and Women’s Hospital. He is also an Affiliate and Course Instructor at the Harvard Medical School’s Center for Bioethics.

His program of work primarily focuses on pharmaceutical and health governance and ethics, with a particular emphasis on how stakeholder input is solicited, structured, and weighted across regulatory and policy settings. A second thread of his research examines drug policy more broadly, with a focus on how medical, commercial, and criminal law systems converge in the regulation of substances such as opioids, nicotine, and psychedelics.

His work has been published in American Journal of Public Health, The American Journal of Bioethics, Social Science & Medicine, JAMA Internal Medicine, and the Journal of Health Politics, Policy and Law, among others.

Daniel received his undergraduate degree from McGill University and his MSc and PhD from the University of Toronto, where he was a Social Sciences and Humanities Research Council Doctoral Fellow. He previously served as a Policy Analyst for Health Canada.

Experience

2024–present Postdoctoral Fellow, Harvard Medical School

Education

2024 University of Toronto, PhD

2019 University of Toronto, MSc

2014 McGill University, BA

MENAFN30032026000199003603ID1110920801

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes